BioSpace News Archive

Seagen Inc. announced that management will participate in a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 2:20 p.m. Eastern Time.

Ora, Inc., the world’s leading partner for ophthalmic pharmaceutical and device development, announced that distinguished ophthalmologist and researcher, Dr. Gustavo De Moraes, MD, PhD, MPH, has accepted the role of Chief Medical Officer.

Arcturus Therapeutics Holdings Inc. announced that members of the Company’s management team will be participating in the SVB Leerink 11th Annual Global Healthcare Conference 2022.

Eureka Therapeutics Receives Orphan Drug Designations for Treatment of Hepatocellular Carcinoma (HCC) With ARTEMIS ® T Cells.

C2i Genomics and Twist Bioscience Corporation today announced a partnership to develop whole-genome cancer reference materials.

Trestle Biotherapeutics today announced that it has entered into a license agreement with Harvard University.

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine, today announced that John Kollins, its President and Chief Executive Officer, will present at the 11th Annual SVB Leerink Global Healthcare Conference.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s HIV and COVID-19 research and development programs at the 29th Conference on Retroviruses and Opportunistic Infections (virtual CROI 2022) taking place from February 12-16.

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be participating in BTIG’s MedTech, Digital Health, Life Science and Diagnostic Tools Conference, taking place virtually from February 15-17, 2022.

Capillary electrophoresis, which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery.